Bevacizumab and Irinotecan in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade Glioma

Clinical trial NCT00381797 · COMPLETED

Trial details

NCT number: NCT00381797
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Childhood Cerebral Anaplastic Astrocytoma Childhood Oligodendroglioma Childhood Spinal Cord Neoplasm Recurrent Childhood Brain Stem Glioma Recurrent Childhood Ependymoma Recurrent Childhood Medulloblastoma

Start date: 2006-08-01
Primary completion: 2015-10-01
Enrollment: 97

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.